Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >UMB-32
UMB-32
  • UMB-32

UMB-32 NEW

Price $123 $540 $950
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-21

Product Details

Product Name: UMB-32 CAS No.: 1635437-39-6
Supply Ability: 10g Release date: 2024/11/21

Product Introduction

Bioactivity

NameUMB-32
DescriptionUMB-32 is a potent and selective BRD4 inhibitor, demonstrating an affinity for BRD4 with a dissociation constant (K d) of 550 nM and an inhibitory concentration 50 (IC 50) of 637 nM. Moreover, UMB-32 exhibits effectiveness against TAF1, a bromodomain-containing transcription factor [1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
KeywordsUMB 32 | UMB-32 | UMB32

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1520.00/25mg
VIP1Y
TargetMol Chemicals Inc.
2024-10-23
$50.00/5mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-19
$0.00/10mg
VIP1Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-17
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY